Senores Pharmaceuticals IPO Subscription.

MAINBOARD

Senores Pharmaceuticals: Category QIB offered 44,43,818 shares, applied 43,47,78,102 shares, with a subscription of 97.84x, and total amount raised is 16,999.82 Cr. Category HNI offered 22,21,909 shares, applied 22,29,63,632 shares, with a subscription of 100.35x, and total amount raised is 8,717.88 Cr. Category BHNI (10L+) offered 14,81,272 shares, applied 14,46,53,764 shares, with a subscription of 97.66x, and total amount raised is 5,655.96 Cr. Category SHNI (2L - 10L) offered 7,40,636 shares, applied 7,83,09,868 shares, with a subscription of 105.73x, and total amount raised is 3,061.92 Cr. Category Retail offered 14,81,272 shares, applied 13,79,95,898 shares, with a subscription of 93.16x, and total amount raised is 5,395.64 Cr. Category Employees offered 75,000 shares, applied 14,94,122 shares, with a subscription of 19.92x, and total amount raised is 58.42 Cr. Category Total offered 82,21,999 shares, applied 79,72,31,754 shares, with a subscription of 96.96x, and total amount raised is 31,171.76 Cr.

Senores Pharmaceuticals: For BHNI (10L+), 2,784 shares were reserved, 53,198 were applied, and the subscription was 19.11x. For SHNI (2L - 10L), 1,392 shares were reserved, 1,41,447 were applied, and the subscription was 101.61x. For Retail, 38,981 shares were reserved, 30,33,409 were applied, and the subscription was 77.82x. For Employees, - shares were reserved, 28,926 were applied, and the subscription was -. Total applications received were 32,56,980.

Category	Offered	Applied	Times	Total Amount (Rs Cr.)
QIB	44,43,818	43,47,78,102	97.84x	16,999.82
HNI	22,21,909	22,29,63,632	100.35x	8,717.88
BHNI (10L+)	14,81,272	14,46,53,764	97.66x	5,655.96
SHNI (2L - 10L)	7,40,636	7,83,09,868	105.73x	3,061.92
Retail	14,81,272	13,79,95,898	93.16x	5,395.64
Employees	75,000	14,94,122	19.92x	58.42
Total	82,21,999	79,72,31,754	96.96x	31,171.76

Last Updated : 24 Dec, 2024 05:57:00 PM

Category	Reserved	Applied	Times
BHNI (10L+)	2,784	53,198	19.11x
SHNI (2L - 10L)	1,392	1,41,447	101.61x
Retail	38,981	30,33,409	77.82x
Employees	-	28,926	-

Total Applications: 3256980

IPO Investor Categories

Qualified Institutional Buyers (QIB)
Institutions like banks, mutual funds, insurance companies, and other SEBI-registered entities fall under the QIB category. They typically invest large sums on behalf of clients or schemes.
Non-Institutional Investors (NII)
This group includes high-net-worth individuals (HNIs), NRIs, trusts, and companies that apply for shares worth more than ₹2 lakhs. Unlike QIBs, SEBI registration is not required.
NII is further split into:
1. sNII (Applications below ₹10 Lakhs)
  Investors bidding between ₹2 lakhs and ₹10 lakhs fall in the Small NII (sHNI) bracket. One-third of the NII portion is set aside for them.
2. bNII (Applications above ₹10 Lakhs)
  Investors applying for more than ₹10 lakhs are classified as Big NIIs (bHNI). Two-thirds of the NII shares are allocated to this sub-category.
Retail Individual Investors (RII)
Individuals or NRIs applying for shares up to ₹2 lakhs are considered retail investors and are part of the RII quota.
Employee (EMP)
This section is reserved for eligible employees of the company participating in the IPO.
Others
Includes eligible shareholders or specific investors with a reserved quota as per the IPO policy.

Read more about Senores Pharmaceuticals IPO

Disclaimer: The above information / data is sourced from National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) websites and is subject to change in real time. For latest information / data, please refer to the respective websites. The information / data provided herein is for informational purposes only and is provided by a2zipo.com on "AS IS" and "AS AVAILABLE" basis and without warranty, express or implied. a2zipo.com does not warrant the accuracy, adequacy or completeness of the information you obtain through the above websites. a2zipo.com shall not be liable in any way for any discrepancies, errors, omissions, losses or damage. a2zipo.com, including its affiliates and its directors, staff and employees, shall not be liable for any loss, damage of any kind, including but not limited to direct, indirect, punitive, exemplary, consequential damages and lost profits arising in any way out of the use of information / data obtained through the said websites. The recipient alone is fully responsible / liable for any decision made based on this information / data. All recipients, before relying on the said information, should do their own research and seek appropriate professional advice.